Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Climb Bio Inc’s stock clocked out at $3.05, up 1.67% from its previous closing price of $3.00. In other words, the price has increased by $1.67 from its previous closing price. On the day, 0.75 million shares were traded. CLYM stock price reached its highest trading level at $3.3 during the session, while it also had its lowest trading level at $3.015.
Ratios:
To gain a deeper understanding of CLYM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 57.73 and its Current Ratio is at 57.73. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 20 ’24 when Pimblett Emily sold 1,191 shares for $8.18 per share. The transaction valued at 9,741 led to the insider holds 7,564 shares of the business.
Morisset Valerie sold 69,005 shares of CLYM for $554,170 on Jul 22 ’24. The EVP, R&D AND CSO now owns 31,317 shares after completing the transaction at $8.03 per share. On Jul 19 ’24, another insider, Morisset Valerie, who serves as the EVP, R&D AND CSO of the company, sold 60,201 shares for $7.21 each. As a result, the insider received 434,325 and left with 100,322 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLYM now has a Market Capitalization of 205032592 and an Enterprise Value of 11739468.
Stock Price History:
Over the past 52 weeks, CLYM has reached a high of $11.55, while it has fallen to a 52-week low of $2.35. The 50-Day Moving Average of the stock is -36.94%, while the 200-Day Moving Average is calculated to be -46.04%.
Shares Statistics:
It appears that CLYM traded 556.27K shares on average per day over the past three months and 324690 shares per day over the past ten days. A total of 67.22M shares are outstanding, with a floating share count of 51.48M. Insiders hold about 23.41% of the company’s shares, while institutions hold 71.05% stake in the company. Shares short for CLYM as of 1730332800 were 4978650 with a Short Ratio of 8.95, compared to 1726185600 on 1152390. Therefore, it implies a Short% of Shares Outstanding of 4978650 and a Short% of Float of 10.27.
